UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)

Molecular psychiatry, 2020-07, Vol.25 (7), p.1592-1603

2020

Volltextzugriff (PDF)

Pharmacological approaches to the challenge of treatment-resistant depression

Dialogues in clinical neuroscience, 2015-06, Vol.17 (2), p.111-126

2015

Volltextzugriff (PDF)

Do the dissociative side effects of ketamine mediate its antidepressant effects?

Journal of affective disorders, 2014-04, Vol.159, p.56-61

2014

Volltextzugriff (PDF)

Effects of esketamine on patient-reported outcomes in major depressive disorder with active suicidal ideation and intent: a pooled analysis of two randomized phase 3 trials (ASPIRE I and ASPIRE II)

Quality of life research, 2023-11, Vol.32 (11), p.3053-3061

2023

Volltextzugriff (PDF)

Monitoring Changes in Depression Severity Using Wearable and Mobile Sensors

Frontiers in psychiatry, 2020-12, Vol.11, p.584711-584711

2020

Volltextzugriff (PDF)

A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression

Psychopharmacology, 2016-03, Vol.233 (6), p.1119-1130

2016

Volltextzugriff (PDF)

Studying pre-treatment and ketamine-induced changes in white matter microstructure in the context of ketamine’s antidepressant effects

Translational psychiatry, 2020-12, Vol.10 (1), p.432-432, Article 432

2020

Volltextzugriff (PDF)

Major depression is not associated with blunting of aversive responses; evidence for enhanced anxious anticipation

PloS one, 2013-08, Vol.8 (8), p.e70969-e70969

2013

Volltextzugriff (PDF)

Esketamine Nasal Spray for Rapid Reduction of Major Depressive Disorder Symptoms in Patients Who Have Active Suicidal Ideation With Intent: Double-Blind, Randomized Study (ASPIRE I)

The journal of clinical psychiatry, 2020-05, Vol.81 (3)

2020

Volltextzugriff (PDF)

Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II)

The international journal of neuropsychopharmacology, 2021-01, Vol.24 (1), p.22-31

2021

Volltextzugriff (PDF)

The Role of Chronic Stress in Anxious Depression

Chronic Stress, 2017-02, Vol.1, p.2470547016689472-2470547016689472

2017

Volltextzugriff (PDF)

Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial

Journal of affective disorders, 2019-01, Vol.243, p.516-524

2019

Volltextzugriff (PDF)

Ketamine-Associated Brain Changes: A Review of the Neuroimaging Literature

Harvard review of psychiatry, 2018-11, Vol.26 (6), p.320-339

2018

Volltextzugriff (PDF)

Esketamine Nasal Spray for the Rapid Reduction of Depressive Symptoms in Major Depressive Disorder With Acute Suicidal Ideation or Behavior

Journal of clinical psychopharmacology, 2021-09, Vol.41 (5), p.516-524

2021

Volltextzugriff (PDF)

Perinatal depressive symptoms often start in the prenatal rather than postpartum period: results from a longitudinal study

Archives of women's mental health, 2021-02, Vol.24 (1), p.119-131

2021

Volltextzugriff (PDF)

Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder

Journal of Neural Transmission, 2014-08, Vol.121 (8), p.907-924

2014

Volltextzugriff (PDF)

Classics in Chemical Neuroscience: Ketamine

ACS chemical neuroscience, 2017-06, Vol.8 (6), p.1122-1134

2017

Volltextzugriff (PDF)

Improvement in suicidal ideation after ketamine infusion: Relationship to reductions in depression and anxiety

Journal of psychiatric research, 2014-11, Vol.58, p.161-166

2014

Volltextzugriff (PDF)

A single infusion of ketamine improves depression scores in patients with anxious bipolar depression

Bipolar disorders, 2015-06, Vol.17 (4), p.438-443

2015

Volltextzugriff (PDF)

Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine: Secondary Analysis of an Open-Label Study

The journal of clinical psychiatry, 2016-06, Vol.77 (6), p.e719-e725

2016

Volltextzugriff (PDF)

Clinical predictors of ketamine response in treatment-resistant major depression

The journal of clinical psychiatry, 2014-05, Vol.75 (5), p.e417-e423

2014

Volltextzugriff (PDF)

Drs Ionescu and Cusin Reply

The journal of clinical psychiatry, 2017-01, Vol.78 (1), p.e72-e72

2017

Volltextzugriff (PDF)

Lithium and Valproate Levels Do Not Correlate with Ketamine’s Antidepressant Efficacy in Treatment-Resistant Bipolar Depression

Neural plasticity, 2015-01, Vol.2015 (2015), p.1-7

2015

Volltextzugriff (PDF)

Defining anxious depression: a review of the literature

CNS Spectrums, 2013-10, Vol.18 (5), p.252-260

2013

Volltextzugriff (PDF)

NEUROBIOLOGY OF ANXIOUS DEPRESSION: A REVIEW

Depression and anxiety, 2013-04, Vol.30 (4), p.374-385

2013

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(61)

Sprache

Englisch
(61)

Erscheinungsjahr

n.n

Thema

Science & Technology
(48)
Life Sciences & Biomedicine
(47)
Psychiatry
(46)
Humans
(41)
Female
(27)
Adult
(25)
Male
(24)
Neurosciences & Neurology
(23)
Middle Aged
(22)
Neurosciences
(21)
Ketamine
(20)
Mental Depression
(20)
Major Depressive Disorder
(19)
Depression
(17)
Depressive Disorder, Major - Drug Therapy
(17)
Young Adult
(15)
Depressive Disorder, Treatment-Resistant - Drug Therapy
(14)
Ketamine - Therapeutic Use
(14)
Clinical Neurology
(13)
Double-Blind Method
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)

Pharmacological approaches to the challenge of treatment-resistant depression

Do the dissociative side effects of ketamine mediate its antidepressant effects?

Effects of esketamine on patient-reported outcomes in major depressive disorder with active suicidal ideation and intent: a pooled analysis of two randomized phase 3 trials (ASPIRE I and ASPIRE II)

Monitoring Changes in Depression Severity Using Wearable and Mobile Sensors

A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression

Studying pre-treatment and ketamine-induced changes in white matter microstructure in the context of ketamine’s antidepressant effects

Major depression is not associated with blunting of aversive responses; evidence for enhanced anxious anticipation

Esketamine Nasal Spray for Rapid Reduction of Major Depressive Disorder Symptoms in Patients Who Have Active Suicidal Ideation With Intent: Double-Blind, Randomized Study (ASPIRE I)

Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II)

The Role of Chronic Stress in Anxious Depression

Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial

Ketamine-Associated Brain Changes: A Review of the Neuroimaging Literature

Esketamine Nasal Spray for the Rapid Reduction of Depressive Symptoms in Major Depressive Disorder With Acute Suicidal Ideation or Behavior

Perinatal depressive symptoms often start in the prenatal rather than postpartum period: results from a longitudinal study

Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder

Classics in Chemical Neuroscience: Ketamine

Improvement in suicidal ideation after ketamine infusion: Relationship to reductions in depression and anxiety

A single infusion of ketamine improves depression scores in patients with anxious bipolar depression

Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine: Secondary Analysis of an Open-Label Study

Clinical predictors of ketamine response in treatment-resistant major depression

Drs Ionescu and Cusin Reply

Lithium and Valproate Levels Do Not Correlate with Ketamine’s Antidepressant Efficacy in Treatment-Resistant Bipolar Depression

Defining anxious depression: a review of the literature

NEUROBIOLOGY OF ANXIOUS DEPRESSION: A REVIEW

Suchergebnisse filtern